MD Anderson and Myriad announced a five-year strategic collaboration to accelerate the clinical evaluation and development of Myriad’s molecular residual disease assay.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
